HealthEquity, Inc. (NASDAQ:HQY) Director Sells $99,847.90 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Frank Corvino also recently made the following trade(s):

• On Tuesday, October 1st, Frank Corvino sold 1,247 shares of HealthEquity stock. The shares were sold at an average price of $80.26, for a total value of $100,084.22.

HealthEquity Price Performance

HealthEquity stock traded up $1.62 during mid-day trading on Friday, reaching $98.82. 666,502 shares of the company’s stock traded hands, compared to its average volume of 616,010. HealthEquity, Inc. has a 12-month low of $62.10 and a 12-month high of $99.57. The company has a market cap of $8.63 billion, a price-to-earnings ratio of 80.91, a PEG ratio of 1.36 and a beta of 0.52. The stock has a 50 day moving average of $82.77 and a two-hundred day moving average of $80.31. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.16. The company had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. Equities analysts forecast that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Hedge Funds Weigh In On HealthEquity

A number of large investors have recently bought and sold shares of the business. International Assets Investment Management LLC acquired a new position in shares of HealthEquity during the 2nd quarter worth about $35,000. Paladin Wealth LLC purchased a new position in shares of HealthEquity in the third quarter valued at approximately $39,000. GAMMA Investing LLC increased its position in shares of HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after purchasing an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in HealthEquity in the 2nd quarter valued at $73,000. Finally, 1620 Investment Advisors Inc. purchased a new position in HealthEquity in the 3rd quarter valued at $112,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Wall Street Analysts Forecast Growth

HQY has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Royal Bank of Canada reiterated an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Barrington Research reaffirmed an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research note on Friday, September 20th. Bank of America dropped their price target on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, September 4th. Finally, JMP Securities reissued a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $103.83.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.